140 related articles for article (PubMed ID: 29805743)
1. A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2.
Daures M; Idrissou M; Judes G; Rifaï K; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Oncotarget; 2018 May; 9(34):23413-23425. PubMed ID: 29805743
[TBL] [Abstract][Full Text] [Related]
2. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
3. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.
Sui A; Xu Y; Li Y; Hu Q; Wang Z; Zhang H; Yang J; Guo X; Zhao W
Oncotarget; 2017 Sep; 8(40):68591-68598. PubMed ID: 28978140
[TBL] [Abstract][Full Text] [Related]
5. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.
Morozov VM; Li Y; Clowers MM; Ishov AM
Oncotarget; 2017 Sep; 8(37):62131-62142. PubMed ID: 28977932
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.
Ngollo M; Lebert A; Daures M; Judes G; Rifai K; Dubois L; Kemeny JL; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2017 Apr; 17(1):261. PubMed ID: 28403887
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus.
Yin H; Wu H; Zhao M; Zhang Q; Long H; Fu S; Lu Q
Oncotarget; 2017 Jul; 8(30):48938-48947. PubMed ID: 28430662
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression analysis of the H3K27 demethylases, JMJD3 and UTX, with the H3K27 methylase, EZH2, in Xenopus.
Kawaguchi A; Ochi H; Sudou N; Ogino H
Int J Dev Biol; 2012; 56(4):295-300. PubMed ID: 22562205
[TBL] [Abstract][Full Text] [Related]
11. Gene networking and inflammatory pathway analysis in a JMJD3 knockdown human monocytic cell line.
Das ND; Jung KH; Choi MR; Yoon HS; Kim SH; Chai YG
Cell Biochem Funct; 2012 Apr; 30(3):224-32. PubMed ID: 22252741
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Profiling and H3K27me3 Distribution Reveal Both Demethylase-Dependent and Independent Regulation of Developmental Gene Transcription in Cell Differentiation.
Kang SC; Kim SK; Chai JC; Kim SH; Won KJ; Lee YS; Jung KH; Chai YG
PLoS One; 2015; 10(8):e0135276. PubMed ID: 26263556
[TBL] [Abstract][Full Text] [Related]
13. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
14. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
[TBL] [Abstract][Full Text] [Related]
15. JMJD3 is a histone H3K27 demethylase.
Xiang Y; Zhu Z; Han G; Lin H; Xu L; Chen CD
Cell Res; 2007 Oct; 17(10):850-7. PubMed ID: 17923864
[TBL] [Abstract][Full Text] [Related]
16. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
[TBL] [Abstract][Full Text] [Related]
17. Targeting H3K27me3 demethylase to inhibit Shh signaling and cholesterol metabolism in medulloblastoma growth.
Deng H; Guo X; Feng N; Luo Y; Liu B; Liu S; Wu JI; Shi X
Front Oncol; 2022; 12():1057147. PubMed ID: 36531063
[TBL] [Abstract][Full Text] [Related]
18. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
Park WY; Hong BJ; Lee J; Choi C; Kim MY
Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
[TBL] [Abstract][Full Text] [Related]
19. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.
Agger K; Cloos PA; Christensen J; Pasini D; Rose S; Rappsilber J; Issaeva I; Canaani E; Salcini AE; Helin K
Nature; 2007 Oct; 449(7163):731-4. PubMed ID: 17713478
[TBL] [Abstract][Full Text] [Related]
20. Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
Uchiyama N; Tanaka Y; Kawamoto T
Eur J Pharmacol; 2017 Oct; 812():138-146. PubMed ID: 28705714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
